Results 121 to 130 of about 20,250 (180)

Trametinib and Fimepinostat Induce Malignant Peripheral Nerve Sheath Tumor Cell Death <i>In Vitro</i>. [PDF]

Cancers (Basel)
Hass EW, Oliveira SA, Fernandez-Valle C.
europepmc   +1 more source

From cell lines to PDXs: in vivo confirmation of synergistic drug responses identified in leukemia cell line models. [PDF]

Blood Neoplasia
Verbeek TCAI, Vrenken KS, Arentsen-Peters STCJM, van den Hoof E, Pieters R, Stam RW.   +5 more
europepmc   +1 more source

Dabrafenib or trametinib in pediatric Langerhans cell histiocytosis with bone lesions: a retrospective efficacy and safety study. [PDF]

BMC Cancer
Ouyang H, Yao H, He C, Zhou Y, Dai J, Wang X, Zeng J, Liu C, Zhong K, Xiao J, Liu X.   +10 more
europepmc   +1 more source

Correction: Alobaidi et al. Combinational Inhibition of MEK and AKT Synergistically Induces Melanoma Stem Cell Apoptosis and Blocks NRAS Tumor Growth. <i>Cells</i> 2025, <i>14</i>, 248. [PDF]

Cells
Alobaidi R, Islam N, Olkey T, Haribabu Y, Shamo M, Sykora P, Simbulan-Rosenthal CM, Rosenthal DS.   +7 more
europepmc   +1 more source

Quantitative BRAF p.V600E mutation monitoring in cerebrospinal fluid cell-free DNA reflects therapeutic response to BRAF/MEK inhibitors in papillary craniopharyngioma: a report of two cases. [PDF]

Acta Neuropathol Commun
Fudaba H, Yanagida M, Takao K, Onishi K, Matsuta H, Momii Y, Anan M, Hata N, Etoh T, Fujiki M.   +9 more
europepmc   +1 more source

Placing purines in precision medicine: Targeting a metabolic reliance in <i>KRAS</i>-mutant tumors. [PDF]

iScience
De Boni L, Claridge S, Nath S, Tofani K, Stein BD, Park E, Steiner S, Elemento O, Pauli C, Hopkins BD.   +9 more
europepmc   +1 more source

High-throughput 3D phenotypic screening identifies repurposed MEK inhibitors as drivers of chondrogenesis for cartilage regeneration. [PDF]

Front Bioeng Biotechnol
Hajiali H, Cholewa-Waclaw J, Ballard J, Okur KE, Elliott R, Carragher NO, El Haj AJ.   +6 more
europepmc   +1 more source

An ex vivo functional biomarker of treatment response in pediatric low-grade glioma. [PDF]

PLoS One
Artz NM, Mann B, Ebbs A, Darawsheh R, Dasari R, Adefolaju A, Bell N, Trembath D, Higgins D, Elton S, Baldwin A, Hingtgen S, Kram DE, Satterlee AB.   +13 more
europepmc   +1 more source

Atrial Septal Defect Surgical Closure Following Trametinib Utilization in Noonan Syndrome-Associated Hypertrophic Cardiomyopathy. [PDF]

JACC Case Rep
Hebson C, Escott S, Beltran-Ale G, Dabal R, Andelfinger G, Linscott K.   +5 more
europepmc   +1 more source

BRAF class II-III mutations in NSCLC: a single center experience. [PDF]

Front Oncol
Torresan S, Bortolot M, Bertoli E, Del Conte A, Stanzione B, de Carlo E, Schiappacassi M, Spina M, Baldassarre G, Bearz A.   +9 more
europepmc   +1 more source